Elizabeth Ng is a distinguished executive in the pharmaceutical and biotech industry, currently serving as the Chief Executive Officer of Ocean Biomedical (NASDAQ: OCEA). She holds an MBA from Stanford and a BS in Physics from MIT. Elizabeth’s leadership journey spans roles from the Senior Director Engagement Manager at Strategic Decisions Group to Director of Commercial Strategy at Gilead, and later roles at Merck and BioMarin.

With extensive experience managing cross-functional executive teams and an expertise across multiple therapeutic areas, particularly oncology, anti-infectives, and orphan diseases, Elizabeth brings a wealth of knowledge and strategic insight to the pharmaceutical and biotech world.